Chronic fatigue syndrome: Evidence supporting the hypothesis of a behaviorally-activated neuromodulator of fatigue

Journal of Chronic Fatigue Syndrome

Volumn 6, Issue 2, 2000, Pages 45-63

  Hurwitz, Barry E ^a   Brownley, Kimberly A ^a   Fletcher, Maryann ^b   Klimas, Nancy G ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adrenal; Autonomic; Cardiovascular; Chronic fatigue syndrome; Cytokine; Immune; Neuromodulator

Indexed keywords

CYTOKINE;

ADRENAL GLAND; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CHRONIC FATIGUE SYNDROME; HUMAN; IMMUNOMODULATION; NEUROMODULATION; NEUROMUSCULAR FUNCTION; PATHOGENESIS; REVIEW;

EID: 0033849014     PISSN: 10573321     EISSN: None     Source Type: Journal    
DOI: 10.1300/J092v06n02_06     Document Type: Review

References (95)

1. Chronic fatigue syndrome
2. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpes virus type 6 infection
3. A psychological assessment of chronic fatigue syndrome and chronic Epstein-Barr virus patients
4. Relationships of cognitive difficulties, depression and illness burden in chronic fatigue syndrome
5. The Chronic fatigue syndrome: A comprehensive approach to its definition and study
6. Chronic fatigue syndrome and psychoneuroimmunology
7. Concurrent sick building syndrome and chronic fatigue syndrome: Epidemic neuromyasthenia revisited
8. Viruses and chronic fatigue syndrome: Current status
9. Cardiac function at rest and with exercise in the chronic fatigue syndrome
10. Aerobic work capacity in patients with chronic fatigue syndrome
11. Exercise performance and fatigability in patients with chromic fatigue syndrome
12. Reduced oxidative muscle metabolism in chronic fatigue syndrome
13. Heterogeneity in chronic fatigue syndrome: Evidence from magnetic resonance spectroscopy of muscle
14. Pathological changes in skeletal muscle: Implications for management
15. Chronic fatigue and myalgia syndrome: Mitochondrial and glycolytic studies in skeletal muscle
16. Human muscle fatigue: Frequency dependence of excitation and force generation
17. Human quadriceps strength and fatigability in patients with postviral fatigue syndrome
18. Normal muscle strength and fatigability in patients with effort syndromes
19. Muscle metabolism, histopathology, and physiology in chronic fatigue syndrome
20. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome
21. Chronic fatigue syndrome: Clinical condition associated with immune activation
22. Immunologic abnormalities in chronic fatigue syndrome
23. Neurochemical links between the nervous and immune systems
24. Physiological implications of the immune-neuro-endocrine network
25. Tilt table testing in fibromyalgia
26. The pathophysiologic roles of interleukin-6 in human disease
27. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders
28. Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: Relation with laboratory and clinical variables and radiological progression in a three year prospective study
29. Interleukin-6 and selected plasma proteins in healthy persons of different ages
30. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men
31. Susceptibility to immunologically mediated fatigue in C57BL/6 versus Balb/c mice
32. Phase I study combining tumor necrosis factor with interferon-alpha and interleukin-2
33. Chronic fatigue syndrome: Identification of distinct subgroups on the basis of allergy and psychologic variables
34. Effect of increased brain serotonergic activity on endurance performance in the rat
35. Serotonergic agonists and antagonists affect endurance performance in the rat
36. Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue
37. The effects of buspirone on perceived exertion and time to fatigue in man
38. Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise
39. Fatigue in HIV-infected men receiving investigational interleukin-2
40. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus
41. Immunity and the pathophysiology of chronic fatigue syndrome
42. Homology of cytokine synthesis inhibitory factor (ELIO) to the Epstein-Barr virus gene BCRFI
43. Viral imitations of host defense proteins. Flattery that turns to battery
44. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence
45. Decreased natural killer well-mediated cytotoxicity per effector cell
46. Interindividual immune status variation patterns in patients with chronic fatigue syndrome: Association with gender and the tumor necrosis factor system
47. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: Interrelations with cellular sources and patterns of soluble immune mediator expression
48. Lymphocyte phenotype and function in chronic fatigue syndrome
49. Decreased natural killer cell activity is associated with severity of chronic fatigue immune deficiency syndrome
50. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome
51. Nervous system-immune system communication
52. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep
53. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement
54. Patterns of immune, neuroendocrine and cardiovascular stress responses in men with asymptomatic human immunodeficiency virus infection
55. Effects of experimental psychological stress on distribution and function of peripheral blood cells
56. Differential effects of active and passive laboratory stressors on immune function in healthy men
57. Central nervous system influences on lymphocyte migration
58. Psychophysiologic strategies in laboratory research
59. Neuroendocrine correlates of chronic fatigue syndrome: A brief review
60. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome
61. Serum neuropeptides in patients with both fibromyalgia (FM) and chronic fatigue syndrome (CFS)
62. Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome
63. Induction of plasma interleukin-6 by circulating adrenaline in the rat
64. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat
65. Recombinant interleukin-6 activates the hypothalamic-pituitaryadrenal axis in humans
66. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: Potential implications for the syndrome of inappropriate vasopressin secretion
67. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs
68. Regulation of pituitary ACTH secretion during chronic stress
69. The relationship between neurally mediated hypotension and the chronic fatigue syndrome
70. Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome
71. Does chronic fatigue syndrome involve the autonomic nervous system?
72. The connection between chronic fatigue syndrome and neurally mediated hypotension
73. Syncope: Mechanisms, approach, and management
74. Cardiac vagal efferent activity and heart period in the carotid sinus reflex
75. Respiratory-heart rate interactions: Psychophysiological implications for pathophysiology and behavior
76. Vagal tone is reduced during paced breathing in patients with the chronic fatigue syndrome
77. Autonomic testing in patients with chronic fatigue syndrome
78. Abnormal left ventricular myocardial dynamics in eleven patients with chronic fatigue syndrome
79. Repetitively negative changing T waves at 24-h electrocardiographic monitors in patients with the chronic fatigue syndrome
80. Cardiovascular response during head-up tilt in chronic fatigue syndrome
81. Chronic fatigue syndrome: Physical and cardiovascular deconditioning
82. Circulating blood volume in chronic fatigue syndrome
83. Depression of lymphocyte traffic in sheep by induced systemic arterial hypotension and by acute arterial occlusion
84. Neurally mediated syncope and serotonin reuptake inhibitors
85. Role of endogenous opioids in syncope induced by head-up tilt test and its relationship with isoproterenol- dependent and isoproterenol-independent neurally-mediated syncope
86. Neurohumoral antecedents of vasodepressor reactions
87. Increase in plasma beta endorphins precedes vasodepressor syncope
88. Interleukin-1 stimulates prostacyclin production by cultured human endothelial cells by increasing arachidonic acid mobilization and conversion
89. Cytokine regulation of endothelial cell function
90. Modulation of endothelial cell functions by different molecular species of interleukin 1
91. The eicosanoids: Prostoglandins, thrombaxanes, leukotrienes, and related compounds
92. Interleukin-I and tumor necrosis factor inhibits cardiac myocyte beta-adrenergic responses